Ligand validation:5YOT

NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose

NAG is a Ligand Of Interest in 5YOT designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5YOT_NAG_B_811	77%	49%	0.102	0.94	0.61	1.37	-	3	0	0	100%	0.9333
5YOT_NAG_A_809	58%	23%	0.121	0.899	0.82	2.51	-	7	0	0	100%	0.9333
5YOT_NAG_A_810	35%	27%	0.216	0.903	1.17	1.93	-	6	0	0	100%	0.9333
5YOT_NAG_A_811	23%	31%	0.227	0.849	1.1	1.73	2	4	0	0	100%	0.9333
5YOT_NAG_B_810	16%	45%	0.263	0.836	0.74	1.41	1	3	0	0	100%	0.9333
5YOT_NAG_B_812	16%	12%	0.255	0.827	1.53	2.71	3	5	0	0	100%	0.9333
5YOT_NAG_A_808	10%	17%	0.278	0.789	1.25	2.54	2	5	0	0	100%	0.9333
5YOT_NAG_A_813	3%	24%	0.381	0.736	1.04	2.19	1	2	0	0	100%	0.9333
5YOT_NAG_A_812	2%	34%	0.34	0.588	0.97	1.71	2	4	0	0	100%	0.9333
5YOT_NAG_B_813	1%	43%	0.358	0.471	0.87	1.37	1	1	0	0	100%	0.9333
7EAP_NAG_A_805	86%	44%	0.086	0.956	0.86	1.35	-	3	0	0	100%	0.9333
5YQS_NAG_B_804	58%	40%	0.155	0.934	0.5	1.85	-	4	0	0	100%	0.9333
1OC7_NAG_A_500	100%	60%	0.04	0.991	0.61	0.9	-	1	0	0	100%	0.9333
1OC6_NAG_A_500	100%	67%	0.041	0.988	0.46	0.8	-	1	0	0	100%	0.9333
1UWC_NAG_A_262	100%	54%	0.046	0.99	0.81	0.95	-	-	0	0	100%	0.9333
6ZE6_NAG_B_703	99%	52%	0.044	0.984	0.78	1.07	-	2	0	0	100%	0.8667
6ZE2_NAG_B_704	99%	56%	0.042	0.979	0.73	0.95	-	1	0	0	100%	0.9333

RCSB PDB Core Operations are funded by the National Science Foundation (DBI-1832184), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.